Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33436 | 92 | 37.3 | 82% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2273 | 4206 | JASMONIC ACID//HYDROPEROXIDE LYASE//ALLENE OXIDE SYNTHASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CHAIR PHARMACOL CLIN PHARMACOL | Address | 3 | 60% | 3% | 3 |
| 2 | HPV E6 AND E7 | Author keyword | 1 | 50% | 2% | 2 |
| 3 | ANHUI PROV CANC HOSP | Address | 1 | 40% | 2% | 2 |
| 4 | H520 | Author keyword | 1 | 50% | 1% | 1 |
| 5 | HUMAN MICROVASCULAR ENDOTHELIAL CELLS HMEC 1 | Author keyword | 1 | 50% | 1% | 1 |
| 6 | MED CLIN MICROBIOL IMMUNOL | Address | 1 | 50% | 1% | 1 |
| 7 | PPG NANOTECNOL FARMACEUT | Address | 1 | 50% | 1% | 1 |
| 8 | CHAIR BIOPHARM | Address | 0 | 33% | 1% | 1 |
| 9 | DENT PHARMACOL NANOSCI | Address | 0 | 33% | 1% | 1 |
| 10 | HMEC 1 CELLS | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HPV E6 AND E7 | 1 | 50% | 2% | 2 | Search HPV+E6+AND+E7 | Search HPV+E6+AND+E7 |
| 2 | H520 | 1 | 50% | 1% | 1 | Search H520 | Search H520 |
| 3 | HUMAN MICROVASCULAR ENDOTHELIAL CELLS HMEC 1 | 1 | 50% | 1% | 1 | Search HUMAN+MICROVASCULAR+ENDOTHELIAL+CELLS+HMEC+1 | Search HUMAN+MICROVASCULAR+ENDOTHELIAL+CELLS+HMEC+1 |
| 4 | HMEC 1 CELLS | 0 | 33% | 1% | 1 | Search HMEC+1+CELLS | Search HMEC+1+CELLS |
| 5 | HUMAN MICROVASCULAR ENDOTHELIUM | 0 | 33% | 1% | 1 | Search HUMAN+MICROVASCULAR+ENDOTHELIUM | Search HUMAN+MICROVASCULAR+ENDOTHELIUM |
| 6 | ONYCHIN | 0 | 33% | 1% | 1 | Search ONYCHIN | Search ONYCHIN |
| 7 | ARTERIAL PERFUSION | 0 | 18% | 2% | 2 | Search ARTERIAL+PERFUSION | Search ARTERIAL+PERFUSION |
| 8 | IGF1 RECEPTOR IGF1R | 0 | 25% | 1% | 1 | Search IGF1+RECEPTOR+IGF1R | Search IGF1+RECEPTOR+IGF1R |
| 9 | POH | 0 | 20% | 1% | 1 | Search POH | Search POH |
| 10 | SECOND MITOCHONDRIA DERIVED ACTIVATOR OF CASPASES | 0 | 17% | 1% | 1 | Search SECOND+MITOCHONDRIA+DERIVED+ACTIVATOR+OF+CASPASES | Search SECOND+MITOCHONDRIA+DERIVED+ACTIVATOR+OF+CASPASES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ASPIRIN METABOLITE SALICYLATE | 4 | 75% | 3% | 3 |
| 2 | MARINE ANTHRAQUINONE | 1 | 50% | 1% | 1 |
| 3 | ODOR DESCRIPTIONS | 1 | 50% | 1% | 1 |
| 4 | SUPPRESS ACTIVATION | 1 | 50% | 1% | 1 |
| 5 | HIGHLY EFFICIENT ELICITORS | 0 | 33% | 1% | 1 |
| 6 | IAP ANTAGONIST | 0 | 25% | 1% | 1 |
| 7 | AKR1C2 | 0 | 20% | 1% | 1 |
| 8 | EMITTING ATOMS | 0 | 17% | 1% | 1 |
| 9 | HUMAN CEREBROMICROVASCULAR ENDOTHELIUM | 0 | 17% | 1% | 1 |
| 10 | P GLYCOPROTEIN ANTAGONIST | 0 | 13% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| The anti-cancer activities of jasmonates | 2013 | 10 | 68 | 37% |
| A Review ( Research and Patents) on Jasmonic Acid and Its Derivatives | 2014 | 3 | 79 | 25% |
| Jasmonates in cancer therapy | 2007 | 47 | 45 | 16% |
| Jasmonates - a new family of anti-cancer agents | 2005 | 41 | 24 | 29% |
| Methyl jasmonate: A plant stress hormone as an anti-cancer drug | 2009 | 38 | 91 | 23% |
| Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family | 2007 | 16 | 42 | 21% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHAIR PHARMACOL CLIN PHARMACOL | 3 | 60% | 3.3% | 3 |
| 2 | ANHUI PROV CANC HOSP | 1 | 40% | 2.2% | 2 |
| 3 | MED CLIN MICROBIOL IMMUNOL | 1 | 50% | 1.1% | 1 |
| 4 | PPG NANOTECNOL FARMACEUT | 1 | 50% | 1.1% | 1 |
| 5 | CHAIR BIOPHARM | 0 | 33% | 1.1% | 1 |
| 6 | DENT PHARMACOL NANOSCI | 0 | 33% | 1.1% | 1 |
| 7 | KERTESZETTUDOMANYI KAR | 0 | 33% | 1.1% | 1 |
| 8 | SACKLER CELLULAR MOL IMAGING | 0 | 33% | 1.1% | 1 |
| 9 | HUMAN DIS RELATED GENE GRP | 0 | 25% | 1.1% | 1 |
| 10 | SISTEMAS DISPERSOS | 0 | 20% | 1.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000134369 | JASMONIC ACID//JASMONATE//METHYL JASMONATE |
| 2 | 0.0000069247 | PERILLYL ALCOHOL//DIETARY ISOPRENOIDS//APOMINE |
| 3 | 0.0000065248 | SALICYLIDENEAMINO 2 THIOPHENOL//GAMABUFOTALIN//INFLAMMATION CONTROL |
| 4 | 0.0000064934 | LIVIN//XIAP//SMAC MIMETICS |
| 5 | 0.0000057361 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
| 6 | 0.0000052908 | TNFAIP1//KCTD7//KCTD10 |
| 7 | 0.0000047679 | VDAC//MITOCHONDRIAL PORIN//VOLTAGE DEPENDENT ANION SELECTIVE CHANNEL |
| 8 | 0.0000044159 | GAMBOGIC ACID//GARCINIA HANBURYI//GAMBOGENIC ACID |
| 9 | 0.0000043995 | PRUNELLA VULGARIS L//PRUNELLA VULGARIS VAR LILACINA//PRUNELLA VULGARIS |
| 10 | 0.0000043661 | CYCLOPENTENONE PROSTAGLANDINS//DELTA12 PROSTAGLANDIN J2//DELTA 12 PROSTAGLANDIN J2 |